| Literature DB >> 29589528 |
Owen L Woodman1, Kai Yee Chin1, Colleen J Thomas2,3, Dominic C H Ng4, Clive N May3.
Abstract
In acute myocardial infarction (AMI), the first line of treatment is to rapidly restore blood flow to the ischemic myocardium to limit infarct size. It is now well established that though clearly beneficial, the positive outcomes of this intervention are limited by injury in response to the reperfusion itself in addition to the prior ischemia. This process is described as reperfusion injury and is considered to contribute to the arrhythmias, microvascular dysfunction and impaired cardiac contractility that is observed even after the restoration of coronary blood flow. Thus an important, currently unmet, therapeutic challenge is to address the outcomes of this reperfusion injury. In this article, we review the evidence that flavonols and flavones may prove useful in preserving cardiac function after ischemia and reperfusion and consider the possible mechanisms, in particular, the inhibition of kinases, by which they may exert protection. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.Entities:
Keywords: Antioxidant; cardioprotection; flavone; flavonol; ischemia-reperfusion; kinase; reactive oxygen species.
Mesh:
Substances:
Year: 2018 PMID: 29589528 DOI: 10.2174/0929867325666180326161730
Source DB: PubMed Journal: Curr Med Chem ISSN: 0929-8673 Impact factor: 4.530